Yingrui Wang-Rosenke

Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat

Stephanie Krämer, Yingrui Wang-Rosenke, Valeska Scholl et al. · American Journal of Physiology-Renal Physiology · 2007 · 65 citations

Glomerular Disease, Immunology, Renal Inflammation +24

S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis

Sebastian Martini, Stephanie Krämer, Tanja Loof et al. · American Journal of Physiology-Renal Physiology · 2007 · 23 citations

Glomerular Disease, Immunology, Pathology +21

The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy

Stephanie Krämer, E. M. Binder, Tanja Loof et al. · American Journal of Physiology-Renal Physiology · 2009 · 16 citations

Hypertension, Renal Pathology, Immunology +18

Stimulation of Soluble Guanylate Cyclase Improves Renal Recovery After Relief of Unilateral Ureteral Obstruction

Yingrui Wang-Rosenke, Alice Mika, Tanja Loof et al. · The Journal of Urology · 2011 · 15 citations

Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis

Stephanie Krämer, Susanne Kron, Yingrui Wang-Rosenke et al. · American Journal of Physiology-Renal Physiology · 2008 · 14 citations

Glomerular Disease, Renal Pathology, Immunology +20